
浏览全部资源
扫码关注微信
纸质出版日期:2011
移动端阅览
王军建, 胡锐. 丹参酮Ⅱ对阿霉素肾病大鼠肾小球nephrin和 TGF-的表达影响[J]. 中国实验方剂学杂志, 2011,17(19):245-251.
WANG Jun-jian, HU-Rui. Effects of Tanshinone Ⅱ on Renal Nephrin and Transforming Growth Factor- of Adriamycin Nephritic Rats[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(19): 245-251.
王军建, 胡锐. 丹参酮Ⅱ对阿霉素肾病大鼠肾小球nephrin和 TGF-的表达影响[J]. 中国实验方剂学杂志, 2011,17(19):245-251. DOI: CNKI:11-3495/R.20110809.1705.011.
WANG Jun-jian, HU-Rui. Effects of Tanshinone Ⅱ on Renal Nephrin and Transforming Growth Factor- of Adriamycin Nephritic Rats[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(19): 245-251. DOI: CNKI:11-3495/R.20110809.1705.011.
目的: 探讨肾小球足细胞跨膜蛋白(nephrin)、转化生长因子-β1(transforming growth factor-β1
TGF-β1)在阿霉素肾病大鼠肾小球中的表达变化及丹参酮 ⅡA对其影响。 方法: SD大鼠56只随机分为2组
模型组44只和对照组12只。模型组大鼠尾静脉一次注射盐酸阿霉素(ADR)0.007 g·kg-1
对照组大鼠尾静脉注射等容积生理盐水
注射ADR 1周后尿蛋白定量>100 mg·(24 h)-1即算建模成功
共有40只大鼠建模成功
随机又分为肾病模型组、泼尼松组、丹参酮ⅡA低剂量组和高剂量组
每组10只。泼尼松组给予泼尼松0.01 g·kg-1·d-1 ig;丹参酮ⅡA低剂量组和高剂量组分别给予丹参酮ⅡA 0.02
0.04 g·kg-1·d-1 ig
共4周。对照组和肾病模型组给予等容积生理盐水ig。实验结束后检测各组大鼠血、尿生化指标
光镜观察肾脏病理学改变
免疫组化技术和Western blotting技术检测nephrin和TGF-β1的表达。 结果: 肾病模型组、泼尼松组、丹参酮ⅡA低剂量组和高剂量组24 h尿蛋白定量、胆固醇、甘油三酯、血尿素氮、血肌酐和肾小球TGF-β1表达均高于对照组(P<0.05)
但泼尼松组和丹参酮ⅡA高剂量组上述指标均低于肾病模型组(P<0.05);肾病模型组、泼尼松组、丹参酮ⅡA低剂量组和高剂量组血清总蛋白、白蛋白、肾小球nephrin表达低于对照组(P<0.05)
但泼尼松组和丹参酮 IIA高剂量组血清总蛋白、白蛋白、nephrin表达高于肾病模型组(P<0.05)。 结论: Nephrin及TGF-β1 在阿霉素肾病发病机制中起重要作用;丹参酮ⅡA能够增加肾组织nephrin的表达
抑制TGF-β1的表达
减少阿霉素肾病大鼠尿蛋白的排出
减轻及延缓肾小球硬化
发挥保护肾脏的作用。
Objective: To explore effects of tanshinone ⅡA on expression changes of nephrin and transforming growth factor-β1(TGF-β1)in adriamycin(ADR)-induced-nephropathy rats. Method: Fifty-six rats of Sprague-Dawley were divided into two groups:the model group(n=44)and the control group(n=12).The rats in the model group were injected with a single dose of ADR(0.007 g·kg-1)via tail-vein
while the rats in the control group were injected with a comparable volume of 0.9% saline. The model was successfully established when the 24 h urinary protein excretion exceeded 100 mg after ADR injection 1 week
forty rats were successful and then were randomly assigned to the ADR nephrosis group(n=10)
prednisone group(n=10)
the low dose and high dose of tanshinone ⅡA group(n=10). The rats in the prednisone group were treated with prednisone(0.01 g·kg-1·d-1)
ig
The rats in the low dose and high dose of tanshinone ⅡA group were treated with tanshinone ⅡA(0.02 g·kg-1·d-1 or 0.04 g·kg-1·d-1)
ig
once a day for 4 weeks
whereas the other rats were received a comparable volume of 0.9% saline. The blood and urina biochemical indicators were measured and the pathological changes of the renal tissues were observed under light microscope
immunohistochemical and Western blotting techniques to detect the expression of nephrin and TGF-β1. Result: The 24 h urinary protein
cholesterol
triglyceride
blood urea nitrogen
serum creatinine
and the expression of TGF-β1 in the ADR nephrosis group
prednisone group
the low dose and high dose of tanshinone ⅡA group were higher than those in the control group(P<0.05). The total protein
albumin and the expression of nephrin in the ADR nephrosis group
prednisone group
the low dose and high dose of tanshinone ⅡA group was lower than those in the control group(P<0.05). After treatment with prednisone and the high dose of tanshinone ⅡA could improve above-mentioned indicators. Conclusion: Nephrin and TGF-β1 play an important role in the pathogenesis of ADR nephrosis; tanshinone ⅡA decreased the urine albumin excretory rate
and prevent the glomemlar sclerosis in rats with ADR nephrosis
which mechanism may be at least partly correlated with enhancing the expression of nephrin and inhibiting the expression of TGF-β1 in kidney.
0
浏览量
2
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621